2006 - Oswald Avery Award, Infectious Diseases Society of America
Cynthia G. Whitney focuses on Streptococcus pneumoniae, Pneumococcal infections, Pediatrics, Immunology and Incidence. Her work carried out in the field of Streptococcus pneumoniae brings together such families of science as Penicillin, Internal medicine, Serotype and Antibiotic resistance. Her Pneumococcal infections research is multidisciplinary, incorporating perspectives in Conjugate vaccine and Pneumonia.
Her research integrates issues of Pregnancy, Bacterial vaccine, Pneumococcal vaccine, Vaccination and Risk factor in her study of Pediatrics. Her research in Incidence intersects with topics in Epidemiology, Pneumococcal conjugate vaccine and Disease. Her research investigates the connection between Pneumococcal conjugate vaccine and topics such as Meningitis that intersect with problems in Confidence interval.
Her main research concerns Streptococcus pneumoniae, Pneumococcal conjugate vaccine, Pediatrics, Pneumococcal infections and Immunology. Her Streptococcus pneumoniae research includes elements of Penicillin, Internal medicine and Serotype, Virology. Her Pneumococcal conjugate vaccine research incorporates elements of Immunogenicity, Pneumococcal disease and Confidence interval.
Her Pediatrics study combines topics from a wide range of disciplines, such as Epidemiology, Incidence, Pneumonia and Vaccination. Cynthia G. Whitney has included themes like Child mortality, Pneumococcal pneumonia and Intensive care medicine in her Pneumonia study. She interconnects Pneumococcal vaccine, Case-control study, Immunization and Pneumococcal polysaccharide vaccine in the investigation of issues within Vaccination.
Cynthia G. Whitney mainly focuses on Pneumococcal conjugate vaccine, Streptococcus pneumoniae, Pediatrics, Pneumonia and Serotype. Her studies in Pneumococcal conjugate vaccine integrate themes in fields like Incidence, Pneumococcal disease, Case-control study, Vaccination and Pneumococcal infections. Her Streptococcus pneumoniae study contributes to a more complete understanding of Microbiology.
Her Pediatrics research incorporates themes from Outbreak, Epidemiology, Disease burden and Credible interval. Her primary area of study in Pneumonia is in the field of Community-acquired pneumonia. Her work in Child mortality addresses subjects such as Conjugate vaccine, which are connected to disciplines such as Intensive care medicine.
Her primary scientific interests are in Pneumonia, Pneumococcal conjugate vaccine, Streptococcus pneumoniae, Community-acquired pneumonia and Pneumococcal infections. Her Pneumonia study combines topics in areas such as Cohort study, Immunology, Health policy, Severity of illness and Conjugate vaccine. Her studies deal with areas such as Serotype and Pediatrics as well as Pneumococcal conjugate vaccine.
Her Streptococcus pneumoniae study necessitates a more in-depth grasp of Microbiology. The Community-acquired pneumonia study combines topics in areas such as Guideline, Sputum and Ambulatory care. Her Pneumococcal infections research focuses on subjects like Meningitis, which are linked to Epidemiology, Pneumococcal disease and Infant newborn.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
Lionel A. Mandell;Richard G. Wunderink;Antonio Anzueto;John G. Bartlett.
Clinical Infectious Diseases (2007)
Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent Adults
Lionel A. Mandell;John G. Bartlett;Scott F. Dowell;Thomas M. File.
Clinical Infectious Diseases (2003)
Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States.
Cynthia G. Whitney;Monica M. Farley;James Hadler;Lee H. Harrison.
The New England Journal of Medicine (2000)
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
Joshua P. Metlay;Grant W. Waterer;Ann C. Long;Antonio Anzueto.
American Journal of Respiratory and Critical Care Medicine (2019)
Effect of Introduction of the Pneumococcal Conjugate Vaccine on Drug-Resistant Streptococcus pneumoniae
Moe H. Kyaw;Ruth Lynfield;William Schaffner;Allen S. Craig.
The New England Journal of Medicine (2006)
Bacterial Meningitis in the United States, 1998-2007
Michael C Thigpen;Cynthia G Whitney;Nancy E Messonnier;Elizabeth R Zell.
The New England Journal of Medicine (2011)
Management of Community-Acquired Pneumonia in the Era of Pneumococcal Resistance: A Report From the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group
James D. Heffelfinger;Scott F. Dowell;James H. Jorgensen;Keith P. Klugman.
JAMA Internal Medicine (2000)
Incidence of Pneumococcal Disease Due to Non-Pneumococcal Conjugate Vaccine (PCV7) Serotypes in the United States during the Era of Widespread PCV7 Vaccination, 1998–2004
Lauri A. Hicks;Lee H. Harrison;Brendan Flannery;James L. Hadler.
The Journal of Infectious Diseases (2007)
Epidemiology of Invasive Streptococcus pneumoniae Infections in the United States, 1995-1998: Opportunities for Prevention in the Conjugate Vaccine Era
Katherine A. Robinson;Wendy Baughman;Gretchen Rothrock;Nancy L. Barrett.
Prevention of perinatal group B streptococcal disease : a public health perspective
Anne Schuchat;Cynthia G. Whitney;Kenneth Zangwill.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: